Cancer Treatment Reviews
Volume 25, Issue 4 , Pages 207-217, August 1999

Pancreatic cancer in patients with chronic pancreatitis: a challenge from a surgical perspective

The Department of Surgery, 251 Hellenic Air Forces (HAF) General Hospital, Athens, Greece

Abstract 

Chronic pancreatitis (CP) is generally considered as a risk factor for pancreatic adenocarcinoma (PAC). However, the cumulative risk differs among the epidemiological studies. In the individual patient, the differential diagnosis between PAC and CP cannot be always resolved preoperatively and even intraoperatively. In those cases, the uncertainty can only be answered with histological studies of the resected specimen after a radical resection, provided that this type of surgery can be performed with a reasonable risk in a surgically fit patient. The type of resection depends on the location of the suspicious mass. For masses in the tail of the pancreas, a distal pancreatectomy is the procedure of choice. For suspicious lesions in the head of the pancreas, a pancreatoduodenectomy (PD) should be performed. The surgeon and the patient should also acknowledge that a radical resection will occasionally be performed for a suspected malignancy only to find that another etiology (i.e. CP) accounts for the suspicious pancreatic mass. In the presence of a strong suspicion for an underlying malignancy in a patient with head dominant CP, PD should probably be preferred over the newer organ-preserving Beger and Frey procedures, since it is an adequate procedure for both CP and PAC.

Keywords: Pancreatic cancer, chronic pancreatitis, idiopathic chronic pancreatitis, familial (hereditary) pancreatitis, pancreatoduodenectomy, distal pancreatectomy, Beger procedure, Frey procedure, proximal pancreatectomy, distal pancreatectomy.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Address for correspondence: E-mail: georgesakorafas@ yahoo.com

PII: S0305-7372(99)90120-2

doi:10.1053/ctrv.1999.0120

Cancer Treatment Reviews
Volume 25, Issue 4 , Pages 207-217, August 1999